Royce & Associates LP boosted its holdings in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 31.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,372,229 shares of the company’s stock after purchasing an additional 329,013 shares during the period. Royce & Associates LP owned approximately 0.68% of Bath & Body Works worth $21,846,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the business. Bank of America Corp DE purchased a new position in shares of Bath & Body Works in the second quarter worth about $62,249,000. 1834 Investment Advisors Co. lifted its stake in shares of Bath & Body Works by 63.8% in the 3rd quarter. 1834 Investment Advisors Co. now owns 316,246 shares of the company’s stock valued at $5,035,000 after acquiring an additional 123,222 shares during the last quarter. Hsbc Holdings PLC lifted its stake in shares of Bath & Body Works by 98.0% in the 2nd quarter. Hsbc Holdings PLC now owns 588,941 shares of the company’s stock valued at $13,651,000 after acquiring an additional 291,470 shares during the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at about $46,706,000. Finally, BlackRock Inc. bought a new stake in shares of Bath & Body Works in the 2nd quarter valued at about $449,065,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on BBWI shares. Jefferies Financial Group increased their target price on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Wells Fargo & Company lifted their price target on Bath & Body Works from $24.00 to $25.00 and gave the stock an “overweight” rating in a research note on Thursday, October 29th. Deutsche Bank set a $22.00 price objective on Bath & Body Works in a research report on Thursday, August 27th. Barclays lowered their price objective on Bath & Body Works from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Thursday, August 27th. Finally, BMO Capital Markets initiated coverage on Bath & Body Works in a research note on Tuesday, September 8th. They set a “market perform” rating and a $20.00 price objective for the company. Four investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works presently has an average rating of “Hold” and an average price target of $22.53.
View Our Latest Analysis on Bath & Body Works
Bath & Body Works Stock Down 0.2%
Shares of Bath & Body Works stock opened at $21.36 on Monday. The firm has a market cap of $4.31 billion, a PE ratio of 5.56, a price-to-earnings-growth ratio of 1.07 and a beta of 1.31. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $24.94. The company’s fifty day simple moving average is $19.21 and its two-hundred day simple moving average is $19.82.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.24 by $0.38. The firm had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company’s revenue for the quarter was down 2.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 2.74 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Friday, November 20th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.7%. Bath & Body Works’s dividend payout ratio (DPR) is presently 20.83%.
About Bath & Body Works
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Stories
- Five stocks we like better than Bath & Body Works
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
